Peroxisome proliferator activated receptors (PPAR) belong to the superfamily of nuclear hormone receptors that heterodimerize with the retinoid X receptor and regulate transcription of several genes involved in lipid metabolism and adipocyte differentiation. Because of the role of 1,25-dihydroxyvitamin D 3 and retinoic acid working through similar receptors (the vitamin D receptor and retinoic acid receptor, respectively) on keratinocyte differentiation, we have examined the effects of activators of PPARα on keratinocyte differentiation. The rate of cornified envelope formation was increased 3-fold in keratinocytes maintained in low calcium (0.03 mM) and incubated in the presence of clofibric acid, a potent PPARα activator. Involucrin, a cornified envelope precursor, and the cross-linking enzyme transglutaminase, were increased at both the message level (2-7-fold) and the protein level (4-12-fold) by clofibric acid. Furthermore,
physiologic doses of the fatty acids oleic acid, linoleic acid, and eicosatetraynoic acid, which are also activators of PPARα, also induced involucrin and transglutaminase protein and mRNA. In contrast, the PPARγ ligand prostaglandin J2 had no effect on protein or mRNA levels of involucrin or transglutaminase. Levels of involucrin and transglutaminase mRNA and protein were induced by clofibric acid in keratinocytes incubated in 1.2 mM calcium, a concentration which by itself induces keratinocyte differentiation. Finally, PPARα activators inhibit DNA synthesis. This study demonstrates that PPARα activators, including putative endogenous ligands such as fatty acids, induce differentiation and inhibit proliferation in keratinocytes, and suggests a regulatory role for the PPARα in epidermal homeostasis. Key word: peroxisome proliferator-activated receptor. J Invest Dermatol 110:368-375, 1998
Although the specific cellular signals that initiate the changes in gene expression regulating the different steps of differentiation remain unknown, calcium has been identified as a key regulator of terminal differentiation. Keratinocytes incubated in medium containing low levels of calcium (0.03 mM) remain in a proliferative, relatively undifferentiated state, whereas keratinocytes maintained in high extracellular calcium concentrations (1.2 mM) express increased levels of differentiation specific proteins, such as INV and TG'ase (Hennings et al, 1989; Fuchs, 1990; Dlugosz and Yuspa, 1994) . These proteins are regulated both at the transcriptional and at the translational levels, and their expression leads to increased rates of cornified envelope (CE) formation (Hennings et al, 1989; Pillai and Bikle, 1991; Dlugosz and Yuspa, 1994; Gibson et al, 1996) .
Other factors such as 1,25-dihydroxyvitamin D 3 , the hormonally active form of vitamin D, have well known effects on keratinocyte proliferation and differentiation. 1,25-dihydroxyvitamin D 3 is a potent inducer of keratinocyte differentiation, and, like calcium, accelerates the appearance of several CE precursor proteins, and inhibits cellular proliferation (Pillai and Bikle, 1991; Itin et al, 1994) . Retinoids and thyroid hormone also affect keratinocyte differentiation, although, in contrast to vitamin D, they inhibit in vitro differentiation and cornification and suppress the expression of differentiation-associated keratins (Isseroff et al, 1989; Blumberg et al, 1992; Fisher and Voorhees, 1996) . Though their effects are diverse, vitamin D 3 , retinoids, and thyroid hormone are all ligands for nuclear hormone receptors in the same superfamily, transcription factors that are heterodimeric partners of the retinoid X-activated receptor (RXR) Kastner et al, 1995) . Recent studies in utero suggest that one or more members of this receptor superfamily may be key regulators of epidermal development. Overexpression of a truncated inactive RARα in fetal murine epidermis results in aberrant cutaneous development, most likely due to subversion of the RXR and its partners (Saitou et al, 1995; Imakado et al, 1995) .
The peroxisome proliferator-activated receptors (PPAR) are also members of the nuclear hormone receptor superfamily. The PPAR subtypes α, δ, and γ are differentially activated by several fatty acids, arachidonic acid metabolites, and hypolipidemic drugs such as clofibrate (Keller et al, 1993; Yu et al, 1995; Forman et al, 1995) . Whereas PPARγ is involved in the regulation of adipocyte differentiation, the α isoform plays a role in lipid metabolism and homeostasis in the liver and kidney (reviewed in Schoonjans et al, 1996) , tissues that, like epidermis, exhibit high rates of fatty acid synthesis. We have recently demonstrated that PPARα activators accelerate the development of the stratum corneum and the epidermal permeability barrier in full thickness fetal rat skin explants incubated in serum-and hormone-free media (Hanley et al, 1997a) . In this study, we sought to determine whether activators of PPARα might also alter the rate of human keratinocyte differentiation in vitro. We report here that activators of PPARα are potent stimulators of keratinocyte differentiation and inhibitors of proliferation.
MATERIALS AND METHODS
Cell culture Human epidermis was isolated from newborn foreskins by incubation in dispase, and a suspension of keratinocytes was obtained by incubation in ethylenediaminotetraacetic acid and subsequent trypsinization, as described by Gibson et al (1996) . The cells were plated in serum-free keratinocyte growth medium (KGM; Clonetics, San Diego, CA), containing 0.07 mM calcium, and grown to 60-80% confluence. Cells were then passaged twice and plated in KGM containing 0.07 mM calcium for 48 h, switched to KGM containing 0.03 mM calcium for 48 h, then treated with either clofibric acid, fatty acids, or vehicle [Ͻ 0.1% dimethylsulfoxide (DMSO) or Ͻ 0.1% ethanol or Ͻ 0.1% ethanol with 0.5% bovine serum albumin], or 1.2 mM calcium with or without clofibric acid, for 0-48 h. Fatty acids and clofibric acid (Sigma, St. Louis, MO) were solubilized in ethanol or DMSO. 15-Deoxy-∆12,14-prostaglandin J2 (Prostaglandin J2) (Cayman, Ann Arbor, MI) was solubilized in DMSO. Fatty acids were complexed with fatty acid-free bovine serum albumin (Sigma) immediately prior to the initiation of each experiment, filtered through a 0.2 µm filter, and added to the culture medium giving a final bovine serum albumin concentration of 100 µM.
RNA isolation
Total RNA was isolated according to the method of Chomczynski et al (1987) . Briefly, cells were lyzed in 4 M guanidine isothiocyanate/25 mM sodium citrate/0.5% sarcosyl/0.1 M β-mercaptoethanol, extracted with phenol-chloroform, and precipitated with ethanol. RNA pellets were suspended in sterile, diethyl pyrocarbonate-treated water, and RNA was quantitated by absorbance at 260 nm using the 260/280 nm ratio as an index of purity.
Northern blotting and cDNA probes Total RNA (15 µg per sample) was size fractionated through a 1% agarose gel containing 2.2 M formaldehyde, as described in Gibson et al (1996) . RNA integrity was visualized following acridine orange staining of the electrophoresed gel. The RNA was transferred to a nylon membrane that was subsequently baked at 80°C for 2 h. Blots were then hybridized with the appropriate 32 P-labeled probe [P1-2 for INV, a gift from Dr. Howard Greene (Harvard, Cambridge, MA), and hTG for keratinocyte transglutaminase 1, a gift from Dr. Robert Rice (UCD, Davis)] overnight at 65°C. Washes were then performed in a solution containing 0.1% sodium citrate/chloride buffer and 0.1% sodium dodecyl sulfate for 20 min at room temperature, followed by a 20 min wash at 65°C. Autoradiography was performed at -70°C. Blots were probed with β-actin to confirm equal loading.
Involucrin and transglutaminase protein levels Protein concentration was assessed by protein electrophoresis and western blotting, as described in Gibson et al (1996) . Briefly, cells were lyzed in 2% sodium dodecyl sulfate and the lysate sonicated. Following protein determination [Bicinchoninic acid protein assay (Pierce, Rockford, IL)], equal amounts of protein were electrophoresed on 7.5% polyacrylamide gels and electroblotted onto membranes. INV protein was detected by incubation overnight at 4°C with a polyclonal rabbit anti-human INV antibody (a gift from Dr. Robert Rice) (1:1000 in Tween 20, 0.5%, and nonfat milk, 5%). Densitometry was used to quantitate INV specific bands on the autoradiograms.
TG'ase protein expression was measured as for INV expression, with modifications as described in Gibson et al (1996) . Briefly, stacking, sample, and running buffers all contained 4 M urea, and following electrophoresis, gels were washed in 4 M urea, 25 mM Tris-HCl, pH 7.4, 75 mM NaCl, 0.1 mM dithiothreitol, and 2 mM ethylenediamine tetraacetic acid for 90 min prior to electroblotting, allowing TG'ase to be detected by BC.1 primary antibody (Thacher, 1989) .
CE formation
The rate of CE formation was determined as described in Gibson et al (1996) . Briefly, cells were incubated with 35 S-methionine/cysteine for 48 h, washed with phosphate-buffered saline, and harvested into 1.1 ml of 2% sodium dodecyl sulfate. Aliquots were reserved for protein determinations. The remaining cell lysate (1 ml) was sonicated briefly (10 s). One milliliter of 4% sodium dodecyl sulfate/4 mM dithiothreitol was then added, and the mixture was heated to Ͼ95 o C for 30 min. Following cooling, sodium dodecyl sulfate/dithiothreitol-insoluble material was collected on filter discs, washed with 0.5% sodium dodecyl sulfate/0.5% dithiothreitol, and quantitated by scintillation spectrophotometry. To determine total protein synthesized during the 48 h of 35 S labeling, a reserved aliquot of the cell lysate (taken prior to heating) was precipitated with an equal volume of 2% bovine serum albumin and 1 ml of 10% (wt/vol) trichloroacetic acid on ice for 30 min, and 35 Slabeled precipitated protein was collected onto filter disks, washed with 5% trichloroacetic acid, and counted in a scintillation counter. Total protein was determined by the method of Bradford (BioRad, Hercules, CA).
DNA content and synthesis DNA content was measured by the method of Labarca et al (1980) . Briefly, cells were incubated for 2 h with bisbenzimidazole (Hoechst 33258, 1 mg per ml) and fluorescence measured with a Perkin-Elmer fluorimeter, excitation 356, emission 458. A standard curve was made using dilutions of calf thymus DNA.
The rate of DNA synthesis was determined by measuring [ 3 H]thymidine incorporation into cellular DNA after 4 h of incubation with 2 µCi [ 3 H]thymidine (110 Ci methyl per mmol, 1Ј2Ј-[ 3 H]thymidine, Amersham, Arlington Heights, IL) per ml media. The radioactivity in the washed trichloroacetic acid precipitate was quantitated by scintillation spectroscopy.
Statistics Statistical analysis was performed using Student's t test.
RESULTS
The PPARα activator clofibric acid induces INV and TG'ase mRNA levels Keratinocytes maintained in low levels of extracellular calcium remain in a proliferative state, expressing relatively low message levels of differentiation-specific proteins such as INV and TG'ase (Pillai and Bikle, 1991; Dlugosz and Yuspa, 1994; Gibson et al, 1996) . To determine whether activators of PPARα induce differentiation in cultured keratinocytes, we first measured INV and TG'ase mRNA levels by northern analysis in cultures maintained in low calcium (0.03 mM), incubated either in the presence of the PPARα activator clofibric acid or in the vehicle, over a 48 h time period. As shown in Fig 1 , levels of INV and TG'ase mRNA in both clofibric acid treated and vehicle treated cells progressively increase throughout the 48 h period; however, clofibric acid treated cells exhibit significantly increased levels of INV compared with vehicle treated cells at all time points examined (6, 12, 24, 48 h), and significantly increased TG'ase mRNA levels at 24 and 48 h (Fig 1) , with a maximal effect on INV at 12-24 h and on TG'ase at 24-48 h (2-7-fold increase over controls in three separate experiments). β-actin mRNA levels remained constant over time, and were unaffected by clofibric acid treatment. These results indicate that the PPARα activator clofibric acid induces two different markers of keratinocyte differentiation.
To determine whether the effect by clofibric acid on INV and TG'ase message levels was concentration dependent, we next measured INV and TG'ase message levels in keratinocytes maintained in 0.03 mM calcium and incubated in the presence of increasing concentrations of clofibric acid. As shown in Fig 2, levels of INV and TG'ase mRNA were significantly increased by 100 µM clofibric acid. Effects of clofibric acid on mRNA levels of both INV and TG'ase were maximal with 200-400 µM. Incubation in 500 µM clofibric acid resulted in toxic effects.
Increased calcium is well known to stimulate keratinocyte differentiation (Hennings et al, 1989; Fuchs, 1990; Pillai and Bikle, 1991; Dlugosz and Yuspa, 1994; Itin et al, 1994; Gibson et al, 1996) . Therefore, we next compared clofibric acid induced message levels of INV and TG'ase with levels induced by 1.2 mM extracellular calcium. mRNA levels of both INV and TG'ase in clofibric acid treated cells maintained in 0.03 mM calcium for 24 h are similar to levels observed in cells incubated for the same time period in the presence of 1.2 mM calcium (Fig 3) . Similar results were obtained after 48 h of treatment (data not shown). These data indicate that clofibric acid is a potent inducer of keratinocyte differentiation, comparable with calcium.
We next determined whether the addition of clofibric acid and high extracellular calcium together might have additive effects on the expression of INV or TG'ase mRNA. Figure 4 shows the time course of INV and TG'ase mRNA induction in cells grown in medium supplemented with 1.2 mM Ca ϩϩ in the presence of clofibric acid or vehicle control. As has been shown previously (Su et al, 1994) , in keratinocytes incubated in high calcium alone, INV mRNA levels increase up to 24 h, and then decline by 48 h, in contrast to keratinocytes maintained in low calcium, in which INV mRNA levels increase up to 48 h (see Fig 1) . TG'ase mRNA levels in cells in high calcium increase up to 24 h and either increase modestly or plateau, as reported previously (Su et al, 1994) . Clofibric acid treated cells exhibit significantly increased mRNA levels of INV at 12, 24, and 48 h compared with high calcium controls (Fig 4) . TG'ase levels increased significantly with clofibric acid treatment compared with vehicle controls at 24 and 48 h; although increased levels were sometimes observed at 6 and 12 h, these changes did not reach statistical significance. Thus, concurrent treatment with the PPARα activator clofibric acid and 1.2 mM calcium significantly increases mRNA levels of the differentiation markers INV and TG'ase compared with 1.2 mM calcium alone.
Fatty acid activators of PPARα also induce INV and TG'ase message levels We next examined the effects of oleic acid, eicosatetraynoic acid, and linoleic acid, which, like clofibric acid, also activate PPARα (Keller et al, 1993; Yu et al, 1995) . As shown in Fig 5, oleic acid (200 µM), eicosatetraynoic acid (25 µM), and linoleic acid (15 µM) concentrations found maximal in dose response studies (data not shown), induce INV and TG'ase message levels µ4-10-fold in keratinocytes maintained in low calcium (0.03 mM). These results demonstrate that the effects on INV and TG'ase mRNA levels are not specific to clofibric acid, but are induced by other PPARα activators and imply that PPARα activation is the common mechanism of action for these effects. In contrast, the PPARγ ligand 15-deoxy-∆12,14-prostaglandin J2 (Su et al, 1994 ) had no effect on INV or TG'ase mRNA levels (data not shown).
INV and TG'ase protein levels are increased by PPARα activators To determine whether the increase in mRNA is associated with changes in protein levels, we next examined protein levels of INV in keratinocytes incubated in 0.03 mM calcium in the presence of clofibric acid or vehicle. As shown in Fig 6(a) , incubation in Fig. 1 . Graphs represent the average of data from two independent experiments (two different donors). A representative autoradiograph is shown here. *p ഛ 0.01, n ϭ 4. increasing concentrations of clofibric acid for 24 h resulted in a progressive increase in INV protein levels (8-12-fold induction by 200-400 µM clofibric acid versus vehicle controls in three separate experiments). The magnitude of the increase was similar to that produced by incubation in high (1.2 mM) extracellular calcium (Fig 6a) . Similar results were observed after 48 h of treatment (data not shown). Clofibric acid also induced a further increase in INV protein in keratinocytes incubated in high calcium (Fig 6b) , i.e., levels of INV protein in keratinocytes incubated in 1.2 mM calcium plus clofibric acid were 2-fold higher than in keratinocytes incubated in 1.2 mM calcium plus vehicle only.
Finally, to determine whether other PPARα activators also increased INV protein levels, we incubated keratinocytes in 0.03 mM calcium in the absence or presence of oleic or linoleic acid, fatty acid activators of the PPARα. As shown in Fig 7, both oleic acid (200 µM) and linoleic acid (15 µM) also induced INV protein expression. In contrast, the PPARγ ligand 15-deoxy-∆12,14-prostaglandin J2 (Su et al, 1994) had no effect on INV protein expression (data not shown).
As has been shown previously by others, TG'ase protein levels were very low in keratinocytes maintained in 0.03 mM calcium (Gibson et al, 1996) . TG'ase protein levels were increased µ3-fold in cells incubated in the presence of clofibric acid for 48 h (Fig 8a) , and increased µ3-fold and 2-fold by oleic acid and linoleic acid, respectively (Fig 8b) . These results indicate that PPARα activators induce protein levels of both INV and TG'ase.
Clofibric acid increases the rate of CE formation An additional, late marker of epidermal differentiation, CE formation, was assessed in cells treated for 48 h with clofibric acid in low (0.03 mM) and in high (1.2 mM) calcium. The results of these studies are shown in Table I and are expressed as the percentage of the vehicle control value in 0.03 calcium (equals 100%). A concentration dependent increase in CE formation is seen with increasing concentrations of clofibric acid, approaching a 4-fold increase (p Ͻ 0.01) with 400 mM clofibric acid in 0.03 mM calcium. Incubation in high calcium alone resulted in an almost 5-fold increase in the rate of CE formation. Yet clofibric acid together with high calcium produced a modest but significant increase over high calcium alone (59% increase, Table I ). Compared with 0.03 mM calcium vehicle, clofibric acid and 1.2 mM calcium resulted in an approximate 6-fold increase in CE synthesis ( Table I) . These data indicate that the PPARα activator clofibric acid increases the rate of CE formation, and that these effects are additive to the increased rate of CE formation induced by high calcium alone.
Keratinocyte growth is inhibited by clofibric acid Cells stimulated to differentiate either by increased extracellular calcium or by 1,25 dihydroxyvitamin D 3 simultaneously exhibit a decrease in cellular proliferation (Pillai and Bikle, 1991; Itin et al, 1994) . To determine if cell growth is similarly inhibited by clofibric acid, we next measured DNA content in keratinocytes incubated for the first 48 h in 0.07 mM calcium (to ensure adhesion) and then switched to low (0.03 mM) calcium medium containing either vehicle or varying concentrations of clofibric acid for the final 48 h. As shown in Table II , DNA content was decreased in a dose dependent manner, with maximal inhibition of µ20% obtained with 400 µM clofibric acid. Thus, similar to other inducers of differentiation such as vitamin D 3 and high calcium, clofibric acid inhibits keratinocyte growth.
We next compared the rate of DNA synthesis in clofibric acid-versus vehicle-treated keratinocytes. Keratinocytes were plated in 0.07 mM calcium for 48 h, and then switched for 24 h to low calcium (0.03 mM) medium containing either vehicle or varying concentrations of clofibric acid. [ 3 H]Thymidine incorporation into DNA was measured during the final 4 h of incubation. A concentration dependent decrease in the rate of DNA synthesis was observed in keratinocytes incubated in the presence of clofibric acid, with a maximal inhibition of µ40% with 400 µM clofibric acid (Table III) . These data indicate that clofibric acid inhibits keratinocyte proliferation.
DISCUSSION
In this study we describe novel effects on keratinocyte differentiation produced by activators of the nuclear hormone receptor PPARα. Clofibric acid is a classical peroxisome proliferator and PPARα activator (Schoonjans et al, 1996) and has been shown previously to activate the peroxisome proliferator response element in cultured murine keratinocytes (Imakado et al, 1995) . The rate of CE formation, an indicator of terminal differentiation, was increased µ3-fold in keratinocytes incubated in the presence of clofibric acid. Protein levels of the CE precursor INV, and the cross-linking enzyme TG'ase, necessary for CE formation, were also increased by clofibric acid. We examined INV and TG'ase regulation by clofibric acid at the message level, and found that mRNA levels of both INV and TG'ase were markedly increased by clofibric acid. Furthermore, other PPARα activators, such as linoleic acid, eicosatetraynoic acid, and oleic acid, fatty acids that activate PPARα as potently as the fibrate family of peroxisomal proliferators (Keller et al, 1993; Yu et al, 1995; Schoonjans et al, 1996) , also significantly increased INV and TG'ase protein and message levels, whereas the PPARγ ligand 15-Deoxy-∆12,14-prostaglandin J2 had no effect. In addition, stimulatory effects on INV and TG'ase protein and message levels by clofibric acid were also observed in keratinocytes incubated in the presence of physiologic calcium levels (1.2 mM). Together, these results strongly suggest that PPARα plays a regulatory role in keratinocyte differentiation.
The nuclear hormone receptor PPARα is a member of the thyroid/ vitamin D/retinoid superfamily of transcription factors that require heterodimerization with the RXR for optimal DNA binding (Mangelsdorf and Evans, 1995; Kastner et al, 1995; . Whereas effects by PPARα activators on keratinocyte differentiation have not been previously reported, it is well known that activators/ligands of other nuclear hormone receptors in this superfamily regulate keratinocyte growth and differentiation. For example, 1,25-dihydroxyvitamin D 3 increases intracellular calcium, promotes terminal differentiation, and inhibits growth of keratinocytes, evidenced by increased levels of INV and TG'ase mRNA, and increased CE formation (Smith et al, 1986; Pillai and Bikle, 1991; Su et al, 1994) . Retinoic acid and its analogs, as well as thyroid hormone, also have well-known effects on the terminal differentiation of keratinocytes, but in contrast to PPARα activators and 1,25-dihydroxyvitamin D 3 , they inhibit cornification in cultured keratinocytes and suppress expression of differentiation specific keratins via their respective nuclear receptors (Isseroff et al, 1989; Blumberg et al, 1992; Fisher and Voorhees, 1996) . Thus, although their effects are diverse, activators/ligands for this nuclear hormone receptor superfamily are important modulators of keratinocyte growth and differentiation. The mechanisms by which the PPARα activators affect keratinocyte differentiation remain unclear. For example, it remains to be determined whether PPARα activators regulate INV and TG'ase gene expression directly.
Studies in vivo also suggest an important role for this superfamily of nuclear receptors in epidermal formation. Overexpression of an abnormal RARα in fetal murine basal epidermal cells results in thin, fragile skin (Saitou et al, 1995) , whereas overexpression in suprabasal cells results in a severe skin phenotype characterized by the absence of mature lamellar membrane structures in the stratum corneum interstices, leading to impaired barrier function (Imakado et al, 1995) . Because the mutated RARα retains its ability to dimerize and bind DNA, but the resultant complex is transcriptionally inactive, signaling pathways dependent on RXR heterodimeric complexes are perturbed. Thus, the superfamily of nuclear hormone receptors may play an important role early in the initial differentiation of keratinocytes and later in the regulation of lipid metabolism crucial to the formation of a functional epidermal barrier.
Our laboratory has been studying fetal epidermal barrier and stratum corneum development. Several hormones that interact with receptors in the nuclear hormone receptor superfamily, such as glucocorticoids, estrogen, and testosterone, affect epidermal ontogenesis when given in pharmacologic doses (Aszterbaum et al, 1993; Hanley et al, 1996a, b) . Furthermore, physiologic concentrations of thyroid hormone, as well as activators of the PPARα and farnesoid X-activated receptor, accelerate the development of the stratum corneum and the epidermal barrier in fetal skin explants (Hanley et al, 1996a (Hanley et al, , 1997a ; however, it is not clear which one or more of these factors are required for the final steps of stratum corneum formation, because development proceeds normally in fetal rat skin explants incubated in hormone-and serumfree medium (Hanley et al, 1996a) . Moreover, fetal mice made hypothyroid due to a mutation in the TSH receptor, though exhibiting a temporary delay in epidermal development prenatally, are born with apparently normal epidermal barriers (Hanley et al, 1997b) . Similarly, PPARα may not be essential in embryonic development, as mice lacking PPARα are born viable and fertile, with no obvious cutaneous defects (Lee et al, 1995) . These data suggest functional redundancy among RXR partners, with a single defect resulting in a mild phenotype. In contrast, overexpression of a mutated RARα that can perturb effective dimerization of this family of hormone receptors results in a dramatic phenotype and demonstrates the central role of RXR in epidermal development.
PPARα is abundant in liver and kidney where it plays a role in the regulation of fatty acid metabolism (reviewed in Schoonjans et al, 1996) . It is activated by molecules that induce peroxisomal proliferation, such as the synthetic agents clofibric acid and WY14,643, used for the therapy of hyperlipidemia, as well as by several free fatty acids (Keller et al, 1993; Yu et al, 1995; Schoonjans et al, 1996) . Because all layers of the epidermis actively synthesize fatty acids (Feingold, 1991) , significant endogenous levels of these fatty acids are likely to be present throughout the epidermis. Indeed, the fatty acid concentrations that induced keratinocyte differentiation in this study (15 µM linoleic acid or 200 µM oleic acid) are consistent with physiologic concentration ranges for fatty acids in the epidermis (0.3-2 mM) and with fatty acid concentrations that activate PPARα in other cell types (Long, 1970; Lampe et al, 1983; Keller et al, 1993; Yu et al, 1995) . Thus, endogenous fatty acids are potential candidates as key local regulators of keratinocyte differentiation. It is of interest that glucocorticoids, which accelerate epidermal barrier development in vivo and in vitro in fetal rats, increase the expression of PPARα mRNA in other cell types (Lemberger et al, 1994; Steineger et al, 1994) . This raises the possibility that the effect of glucocorticoids on epidermal formation may be mediated via PPARα.
In summary, we demonstrate here that activators of the nuclear hormone receptor PPARα, a member of the vitamin D receptor/ RAR/RXR superfamily of transcription factors, induce keratinocyte differentiation. These studies, taken together with evidence that PPARα activators accelerate fetal epidermal maturation, suggest a physiologic role for PPARα in epidermal homeostasis.
